NCT03785574 2026-03-16
Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
Clinical Trials
51 trialsNCT05763199 2026-03-12
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy
University of California, Davis
Phase 2 Active not recruiting
NCT04575935 2026-03-05
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
M.D. Anderson Cancer Center
Phase 3 Recruiting
NCT04857528 2026-03-04
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
Recruiting
NCT07033819 2026-02-27
Neoadjuvant Treatment of Ovarian Cancer With Fuzuloparib in Combination With Apatinib
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2 Recruiting
NCT03943173 2026-02-25
Olaparib in Treating Patients With Newly Diagnosed BRCA-Mutant Ovarian, Primary Peritoneal, or Fallopian Cancer Before Surgery
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT07340489 2026-01-14
Serplulimab for Locally Advanced Cervical Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting
NCT06529809 2025-12-24
Accelerated Brachytherapy Forward Chemo Radiation Therapy (ABC-RT) for Locally-advanced Cervical Cancer
Washington University School of Medicine
Phase 1/2 Recruiting
NCT07167160 2025-12-18
Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Recruiting
NCT07244965 2025-11-24
Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer
Women's Hospital School Of Medicine Zhejiang University
Phase 2 Not yet recruiting
NCT06877572 2025-10-27
ECS Weight
University of Kansas Medical Center
Recruiting
NCT02122185 2025-06-08
Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
University of Chicago
Phase 2 Active not recruiting
NCT06990503 2025-05-25
SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer
Tongji Hospital
Phase 3 Not yet recruiting
NCT05857631 2025-04-15
PARCERII
Tata Memorial Centre
Phase NA Recruiting
NCT05704621 2025-03-06
SOCCER-P
Korea University Guro Hospital
Phase 2 Recruiting
NCT03314740 2025-01-10
BAROCCO
Mario Negri Institute for Pharmacological Research
Phase 2 Completed
NCT05255653 2024-11-29
RAINBO
Leiden University Medical Center
Phase 2/3 Recruiting
NCT05183984 2024-10-16
NIRVANA-1
ARCAGY/ GINECO GROUP
Phase 2 Recruiting
NCT05684731 2024-08-13
K19017-004
Tongji Hospital
Phase 1 Recruiting
NCT03539406 2024-08-09
INTRO
Radboud University Medical Center
Phase 1 Completed
NCT06535334 2024-08-02
Intraperitoneal Chemotherapy in Recurrent Ovarian Cancer
Far Eastern Memorial Hospital
Not yet recruiting
NCT05143970 2024-03-20
CHANCES
Institut Paoli-Calmettes
Phase 1 Unknown
NCT03757858 2024-02-07
Hyperthermia Combined With Immunotherapy in the Treatment of Abdominal and Pelvic Malignancies or Metastases
Capital Medical University
Phase 1/2 Completed
NCT05076942 2023-08-01
GROINSS-VIII
University Medical Center Groningen
Phase 2 Recruiting
NCT05410938 2023-07-10
Intraperitoneal Chemotherapy Versus Triweekly Chemotherapy
Far Eastern Memorial Hospital
Completed
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT05541146 2023-03-23
Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal Carcinomatosis
Instituto do Cancer do Estado de São Paulo
Phase 2 Unknown
NCT05733806 2023-02-23
MITO9B
National Cancer Institute, Naples
Recruiting
NCT05524389 2022-11-23
Study of Early Stage Endometrial Cancer Based on Molecular Classification and Traditional Risk Stratification to Guide Adjuvant Radiotherapy Decisions
Peking Union Medical College Hospital
Phase 3 Not yet recruiting
NCT05607329 2022-11-07
Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial
Women's Hospital School Of Medicine Zhejiang University
Phase NA Recruiting
NCT05437692 2022-10-12
Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Shanghai Zhongshan Hospital
Phase 2 Unknown
NCT01809379 2022-07-08
Intraperitoneal Aerosol High-pressure Chemotherapy for Women With Recurrent Ovarian Cancer
Ruhr University of Bochum
Phase 2 Completed
NCT05422183 2022-06-16
Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer
Zhongda Hospital
Phase 2 Unknown
NCT04756713 2022-05-27
ReCure
Brigham and Women's Hospital
Phase 3 Unknown
NCT02067052 2022-04-15
New Strategy for the Treatment of Vulvar Cancer
Instituto do Cancer do Estado de São Paulo
Unknown
NCT04795596 2022-04-15
Secondary Cytoreductive Surgery in Platinum-resistant Recurrent Ovarian Cancers
Menoufia University
Phase 2/3 Withdrawn
NCT04188847 2022-03-15
First-line Chemotherapy for Recurrent Cervical Cancer
Peking Union Medical College Hospital
Phase 2 Completed
NCT03955367 2022-02-23
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05170594 2021-12-28
A Study of Bevacizumab Combined With Fluzoparib/Chemotherapy or Fluzoparib in the Treatment of Ovarian Cancer
The Second Affiliated Hospital of Shandong First Medical University
Phase 2 Unknown
NCT04620954 2021-12-01
ORION-02
National Cancer Centre, Singapore
Phase 1/2 Unknown
NCT05059782 2021-09-28
Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer
Xi'an Jiaotong University
Phase NA Unknown
NCT03308604 2021-07-07
NANOCOL
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1 Unknown
NCT04747717 2021-02-11
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer
N.N. Petrov National Medical Research Center of Oncology
Phase NA Unknown
NCT04635956 2020-11-19
Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas
Peking Union Medical College Hospital
Phase 2 Unknown
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT03332069 2017-11-07
mEHT
University of Witwatersrand, South Africa
Phase 3 Unknown
NCT03175848 2017-07-21
Chemotherapy Plus Radiation Therapy in Treating Patients With Primary Stage IVB Cervical Cancer
Zhejiang Cancer Hospital
Phase NA Unknown
NCT02606539 2017-03-22
SVCGTN
Mansoura University
Phase 2/3 Unknown
NCT01917695 2015-08-13
Study on Early Stage Bulky Cervical Cancers
Government Royapettah Hospital
Phase 3 Unknown
NCT00003358 2013-01-16
Cisplatin and Gemcitabine in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed